Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Gradalis reports on novel autologous tumor cell vaccine for advanced cancer

June 4, 2008

New treatment options for cancer reported in recent patent literature

June 4, 2008

Adherex presents phase I/II results on ADH-1, a novel N-cadherin-targeting oncolytic

June 4, 2008

TransMolecular initiates phase I unlabeled TM-601 trial in malignant glioma

June 3, 2008

Enzon reports phase I results of EZN-2208 and EZN-2232

June 3, 2008

Early evidence of activity with ABT-263 in treating lymphoid malignancies

June 3, 2008

Phase I study of seliciclib and Tarceva in advanced cancers scheduled to begin

June 3, 2008

CureVac enters licensing agreement with LICR for three tumor-associated antigens

June 3, 2008

Human Genome Sciences has initiated dosing in phase I HGS-1029

June 2, 2008

Phase I data show activity of NKTR-102 in solid tumor patients

June 2, 2008

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...